Aspiriant LLC’s TransDigm Group TDG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.17M Sell
2,000
-2
-0.1% -$2.4K 0.05% 110
2026
Q2
$2.67M Buy
2,002
+2
+0.1% +$2.46K 0.07% 94
2026
Q1
$2.32M Sell
2,000
-1
-0% -$1.31K 0.07% 99
2025
Q4
$2.66M Buy
2,001
+1
+0.1% +$1.31K 0.08% 94
2025
Q3
$2.64M Sell
2,000
-6
-0.3% -$8.58K 0.08% 87
2025
Q2
$3.05M Sell
2,006
-14
-0.7% -$19.7K 0.1% 86
2025
Q1
$2.79M Buy
2,020
+7
+0.3% +$9.33K 0.1% 81
2024
Q4
$2.55M Buy
2,013
+12
+0.6% +$15.8K 0.09% 86
2024
Q3
$2.86M Buy
+2,001
New +$2.6M 0.11% 79

Other funds holding TDG

Aspiriant LLC's TDG Position: Q3 2026 in Review

Aspiriant LLC reduced its TransDigm Group (TDG) stake by 0.1% in Q3 2026, selling an estimated $2.4K and leaving 2,000 shares worth $2.17M. The position accounts for 0.05% of the portfolio, ranked #110.

Aspiriant LLC first reported a position in TDG in Q3 2024 and has held it in 9 quarters since. The position peaked at $3.05M in Q2 2025. 1,108 funds tracked by Wall St. Rank hold TDG as of Q3 2026.

  • Aspiriant LLC held 2,000 shares of TransDigm Group worth $2.17M as of Q3 2026.
  • Aspiriant LLC sold 2 TransDigm Group shares in Q3 2026, an estimated $2.4K.
  • TransDigm Group made up 0.05% of Aspiriant LLC's portfolio in Q3 2026, its #110 holding.
  • Aspiriant LLC first reported a position in TransDigm Group in Q3 2024 and has held it in 9 quarters since.
  • Aspiriant LLC's TransDigm Group position peaked at $3.05M in Q2 2025.
  • 1,108 funds tracked by Wall St. Rank held TransDigm Group as of Q3 2026.

Based on Aspiriant LLC's 13F filing for Q3 2026, filed 16 Oct 2026.